A detailed history of Alberta Investment Management Corp transactions in Maxcyte, Inc. stock. As of the latest transaction made, Alberta Investment Management Corp holds 109,545 shares of MXCT stock, worth $411,889. This represents 0.01% of its overall portfolio holdings.

Number of Shares
109,545
Previous 136,135 19.53%
Holding current value
$411,889
Previous $639,000 28.33%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$3.94 - $5.38 $104,764 - $143,054
-26,590 Reduced 19.53%
109,545 $458,000
Q4 2023

Feb 12, 2024

SELL
$2.6 - $5.24 $165,588 - $333,725
-63,688 Reduced 31.87%
136,135 $639,000
Q3 2023

Nov 14, 2023

BUY
$3.02 - $5.1 $69,493 - $117,356
23,011 Added 13.01%
199,823 $623,000
Q2 2023

Aug 14, 2023

BUY
$3.69 - $5.35 $652,436 - $945,944
176,812 New
176,812 $811,000

Others Institutions Holding MXCT

About MAXCYTE, INC.


  • Ticker MXCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 101,724,000
  • Market Cap $382M
  • Description
  • MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...
More about MXCT
Track This Portfolio

Track Alberta Investment Management Corp Portfolio

Follow Alberta Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.